Combined action on the heart of beta adrenergic blocking agents and anti-arrhythmia drugs
Mazurowa, A.; Szadowska, A.; Szmigielski, A.
Kardiologia Polska 15(2): 167-175
1972
ISSN/ISBN: 0022-9032 PMID: 4403276 Document Number: 48286
Document emailed within 1 workday
Related Documents
Witkowska, M. 1982: Clinical pharmacology of anti-arrhythmia agents. III. Drugs blocking beta adrenergic receptors Kardiologia Polska 25(2): 147-161Tuna, J.L. 1992: Classification of anti-arrhythmia drugs and their mechanism of action. Iatrogeny of anti-arrhythmia agents Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 11(4): 385-386
Holland, M.G. 1974: Autonomic drugs in ophthalmology: Some problems and promises. Section IV: Sympatholytic and sympathetic blocking agents--alpha adrenergic antagonists and beta adrenergic antagonists Annals of Ophthalmology 6(11): 1139-1142
Imai, S. 1975: Action mechanism of anti-hypertensive drugs, with special reference to beta blocking drugs Nihon Jinzo Gakkai Shi 17(7): 674-677
Lumholtz, I.B. 1981: Drug information: agents for the treatment of arrhythmias. Therapeutic main group: anti-arrhythmia agents. 16. (3). Anti-arrhythmia agents with action on ventricular arrhythmias Sygeplejersken 81(2): 15
Harms, H.H. 1976: Isoproterenol antagonism of cardioselective beta adrenergic receptor blocking agents: a comparative study of human and guinea-pig cardiac and bronchial beta adrenergic receptors Journal of Pharmacology and Experimental Therapeutics 199(2): 329-335
Slawin, S. 1973: Beta adrenergic blocking drugs Harefuah 85(4): 178-183
Colace, F. 1970: Pharmacology and clinical use of adrenergic beta-blocking agents Il Policlinico. Sezione Pratica 77(20): 645-656
Canale, J.M.; Horwitz, S. 1979: Therapeutic scope of beta-adrenergic blocking agents Archivos de Investigacion Medica 10(4): 261-277
Letts, L.G.; Easson, P.A.; Temple, D.M.; Williams, L.R.; Pasaribu, S.J.; Lap, B.V.; Lim, C.H. 1979: Beta-Adrenergic blocking action of halonitrophenethanolamines Archives Internationales de Pharmacodynamie et de Therapie 238(1): 105-113
Walters, L.; Dormehl, I.; Goosen, D.J.; Avenant, J.C.; Du Plessis, M.; Jacobs, N.; Schoeman, H.S. 1983: Beta-adrenergic blocking drugs and renal function South African Medical Journal 64(15): 572-573
Madan, B.R.; Gupta, R.S. 1970: Effect of adrenergic beta receptor blocking agents on cardiac output Indian Heart Journal 22(2): 70-72
Tafreshi, M.J.; Weinacker, A.B. 1999: Beta-adrenergic-blocking agents in bronchospastic diseases: a therapeutic dilemma PharmacoTherapy 19(8): 974-978
Lydtin, H. 1975: The significance of beta-adrenergic receptor blocking agents in the treatment of hypertension Die Medizinische Welt 6(35): 1487-1492
Sharma, P.L. 1976: Clinical pharmacology of adrenergic beta-receptor blocking drugs Journal of the Association of Physicians of India 24(11): 729-735
Gettes, L.S. 1970: Beta adrenergic blocking drugs in the treatment of cardiac arrhythmias Cardiovascular Clinics 2(2): 211-237
Chichkanov, G.G.; Bogolepov, A.K.; Matsievskiĭ, D.D. 1981: Mechanism of the effect of anti-angina drugs with adrenergic beta receptor agonist action on the collateral hemodynamics and redistribution of the blood flow in chronic myocardial ischemia Kardiologiia 21(10): 85-88
Zebrowska-Lupina, I. 1978: Studies on the mechanisms of central action of alpha-adrenergic receptor blocking agents Polish Journal of Pharmacology and Pharmacy 30(4): 455-458
Nosál', R.; Drábiková, K.; Pecivová, J. 1988: Adverse effects of beta-adrenergic receptor blocking agents on the cellular level Casopis Lekaru Ceskych 127(5): 133-136
Klevans, L.R.; Kovacs, J.L.; Kelly, R. 1976: Central effect of beta adrenergic blocking agents on arterial blood pressure Journal of Pharmacology and Experimental Therapeutics 196(2): 389-395